Cargando…

Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart

Heart failure remains a major health burden around the world. Despite great progress in delineation of molecular mechanisms underlying development of disease, standard therapy has not advanced at the same pace. The multifunctional signaling molecule Ca(2+)/calmodulin-dependent protein kinase II (CaM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nassal, Drew, Gratz, Daniel, Hund, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012788/ https://www.ncbi.nlm.nih.gov/pubmed/32116711 http://dx.doi.org/10.3389/fphar.2020.00035

Ejemplares similares

Ca(2+)/calmodulin kinase II–dependent regulation of β(IV)-spectrin modulates cardiac fibroblast gene expression, proliferation, and contractility
por: Nassal, Drew M., et al.
Publicado: (2021)

Regulation of Cardiac Conduction and Arrhythmias by Ankyrin/Spectrin-Based Macromolecular Complexes
por: Nassal, Drew, et al.
Publicado: (2021)

Prolyl Isomerase Pin1 Directly Regulates Calcium/Calmodulin-Dependent Protein Kinase II Activity in Mouse Brains
por: Shimizu, Taiki, et al.
Publicado: (2018)

Oxidized Calmodulin Kinase II Regulates Conduction Following Myocardial Infarction: A Computational Analysis
por: Christensen, Matthew D., et al.
Publicado: (2009)

Ca(2+)/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy
por: Duran, Javier, et al.
Publicado: (2017)

The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders
por: Sałaciak, Kinga, et al.
Publicado: (2021)

Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II
por: Mustroph, Julian, et al.
Publicado: (2022)

Targeting Autophagy to Treat Cancer: Challenges and Opportunities
por: Lim, Junghyun, et al.
Publicado: (2020)

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
por: Biber, Knut, et al.
Publicado: (2019)

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges
por: Bansal, Isha, et al.
Publicado: (2023)

Resveratrol Inhibits Neuronal Apoptosis and Elevated Ca(2+)/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Mouse Retina
por: Kim, Young-Hee, et al.
Publicado: (2010)

Calmodulin kinase II initiates arrhythmogenicity during metabolic acidification in murine hearts
por: Pedersen, T H, et al.
Publicado: (2009)

Calcium Signalling in Heart and Vessels: Role of Calmodulin and Downstream Calmodulin-Dependent Protein Kinases
por: Beghi, Sofia, et al.
Publicado: (2022)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities
por: Li, Wen-Hao, et al.
Publicado: (2023)

Pharmacogenetics – Challenges and Opportunities Ahead
por: Zanger, Ulrich M.
Publicado: (2010)

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
por: Rah, Bilal, et al.
Publicado: (2022)

Function of calmodulin in postsynaptic densities. II. Presence of a calmodulin- activatable protein kinase activity
por: Grab, DJ, et al.
Publicado: (1981)

Biophysical analysis of the dynamics of calmodulin interactions with neurogranin and Ca(2+)/calmodulin‐dependent kinase II
por: Seeger, Christian, et al.
Publicado: (2017)

Assemblies of calcium/calmodulin-dependent kinase II with actin and their dynamic regulation by calmodulin in dendritic spines
por: Wang, Qian, et al.
Publicado: (2019)

Inhibition of TRPP3 by calmodulin through Ca(2+)/calmodulin-dependent protein kinase II
por: Liu, Xiong, et al.
Publicado: (2023)

Calcium/calmodulin-dependent kinase II and Alzheimer’s disease
por: Ghosh, Anshua, et al.
Publicado: (2015)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Calcium/Calmodulin–Dependent Protein Kinase II in Cerebrovascular Diseases
por: Zhang, Xuejing, et al.
Publicado: (2021)

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
por: Sudhesh Dev, Sareshma, et al.
Publicado: (2021)

Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases
por: Zhang, Fangling, et al.
Publicado: (2022)

Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition–An Outstanding Challenge
por: Fintha, Attila, et al.
Publicado: (2019)

Calcium calmodulin kinase II activity is required for cartilage homeostasis in osteoarthritis
por: Nalesso, Giovanna, et al.
Publicado: (2021)

Editorial: Today's Nutrition and Tomorrow's Public Health: Challenges and Opportunities
por: Lenoir-Wijnkoop, Irene, et al.
Publicado: (2016)

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023)

Editorial: Opportunities and challenges in reusing public genomics data
por: Ahmed, Mahmoud, et al.
Publicado: (2023)

Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches
por: Ribba, Benjamin, et al.
Publicado: (2023)

Calcium/calmodulin kinase II activity of hippocampus in kainate-induced epilepsy.
por: Lee, M. C., et al.
Publicado: (2001)

The role of calmodulin and calmodulin-dependent protein kinases in the pathogenesis of atherosclerosis
por: Chen, Mei-Fang
Publicado: (2021)

Lobe-specific Functions of Ca(2+)·Calmodulin in αCa(2+)·Calmodulin-dependent Protein Kinase II Activation
por: Jama, Abdirahman M., et al.
Publicado: (2011)

Phosphoproteomics Study Based on In Vivo Inhibition Reveals Sites of Calmodulin‐Dependent Protein Kinase II Regulation in the Heart
por: Scholten, Arjen, et al.
Publicado: (2013)

Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
por: Alshaker, Heba, et al.
Publicado: (2019)

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016)

Improving Pediatric Drug Development: Challenges, Opportunities and Lessons Learned
por: Mattison, Donald R.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kuekhbvld5q7moh25buce294gi